2025-01-20 IDOPRESS
BEIJING,Jan. 17,2025 -- Baidu,Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"),a leading AI company with strong Internet foundation,today announced that it will report its financial results for the Fourth Quarter and Fiscal Year 2024 ended December 31,2024,before the U.S. market opens on February 18,2025. Baidu's management will hold an earnings conference call at 7:30 AM on February 18,2025,U.S. Eastern Time (8:30 PM on February 18,Beijing Time).
Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of "Baidu Inc. Q4 2024 Earnings Conference Call". Please follow the steps to enter your registration details,then click "Register". Upon registering,you will then be provided with the dial-in number,the passcode,and your unique access PIN. This information will also be emailed to you as a calendar invite.
For pre-registration,please click:
https://s1.c-conf.com/diamondpass/10044727-f3pyuq.html
In the 10 minutes prior to the call start time,you may use the conference access information (including dial-in number(s),the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.
Additionally,a live and archived webcast of this conference call will be available at https://ir.baidu.com.
A replay of the conference call may be accessed by phone at the following number until February 25,2025:
US: 1 855 883 1031
Reply PIN: 10044727
About Baidu
Founded in 2000,Baidu's mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation,trading on Nasdaq under "BIDU" and the HKEX under "9888." One Baidu ADS represents eight Class A ordinary shares.
Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share
Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion
LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025
2025 Global Sources Hong Kong Shows: Shaping the Future of Consumer Trends and Redefining Sourcing
©copyright 2009-2020 Diet Tips Daily